Cite
MP49-09 ACTIVATION OF IFN/STAT1 SIGNALING IN CISPLATIN/GEMCITABINE RESISTANT BLADDER CANCER
MLA
Akio Matsubara, et al. “Mp49-09 Activation of Ifn/Stat1 Signaling in Cisplatin/Gemcitabine Resistant Bladder Cancer.” Journal of Urology, vol. 193, Apr. 2015. EBSCOhost, https://doi.org/10.1016/j.juro.2015.02.513.
APA
Akio Matsubara, Colin Collins, Robert H. Bell, Kendric Wang, Manuel Altamirano-Dimas, Tilman Todenhoefer, Peter McL. Black, Kilian M. Gust, Shannon Awrey, Susan Ettinger, Tetsutaro Hayashi, Wolfgang Jäger, & Roland Seiler. (2015). Mp49-09 Activation of Ifn/Stat1 Signaling in Cisplatin/Gemcitabine Resistant Bladder Cancer. Journal of Urology, 193. https://doi.org/10.1016/j.juro.2015.02.513
Chicago
Akio Matsubara, Colin Collins, Robert H. Bell, Kendric Wang, Manuel Altamirano-Dimas, Tilman Todenhoefer, Peter McL. Black, et al. 2015. “Mp49-09 Activation of Ifn/Stat1 Signaling in Cisplatin/Gemcitabine Resistant Bladder Cancer.” Journal of Urology 193 (April). doi:10.1016/j.juro.2015.02.513.